![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 9
Zeitschriftenartikel
Bartova, Lucie; Dold, Markus; Volz, Hans-Peter; Seifritz, Erich; Moeller, Hans-Juergen und Kasper, Siegfried
(2022):
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 273: S. 51-63
Volz, Hans-Peter; Saliger, Julia; Kasper, Siegfried; Moeller, Hans-Juergen und Seifritz, Erich
(2022):
Subsyndromal generalised anxiety disorder: operationalisation and epidemiology - a systematic literature survey.
In: International Journal of Psychiatry in Clinical Practice, Bd. 26, Nr. 3: S. 277-286
Seifritz, Erich; Kasper, Siegfried; Moeller, Hans-Juergen; Volz, Hans-Peter; Mueller, Walter E.; Eckert, Anne und Hatzinger, Martin
(2022):
Effect of anxiolytic drug silexan on sleep - a narrative review.
In: World Journal of Biological Psychiatry, Bd. 23, Nr. 7: S. 493-500
Moeller, Hans-Jürgen; Volz, Hans-Peter; Seifritz, Erich; Mueller, Heiko; Kenntner-Mabiala, Ramona; Kaussner, Yvonne; Schoch, Stefanie und Kasper, Siegfried
(2021):
Silexan does not affect driving performance after single and multiple dose applications: Results from a double-blind, placebo and reference-controlled study in healthy volunteers.
In: Journal of Psychiatric Research, Bd. 136: S. 543-551
Seifritz, Erich; Moeller, Hans-Jürgen; Volz, Hans-Peter; Mueller, Walter E.; Hopyan, Talar; Wacker, Anna; Schlaefke, Sandra und Kasper, Siegfried
(2021):
No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled Trial.
In: International Journal of Neuropsychopharmacology, Bd. 24, Nr. 3: S. 171-180
Moeller, Hans-Jürgen; Volz, Hans-Peter; Dienel, Angelika; Schlaefke, Sandra und Kasper, Siegfried
(2019):
Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 269, Nr. 2: S. 183-193
Kasper, Siegfried; Müller, Walter E.; Volz, Hans-Peter; Möller, Hans-Jürgen; Koch, Egon und Dienel, Angelika
(2018):
Silexan in anxiety disorders: Clinical data and pharmacological background.
In: World Journal of Biological Psychiatry, Bd. 19, Nr. 6: S. 412-420
Kasper, Siegfried; Möller, Hans-Jürgen; Volz, Hans-Peter; Schläfke, Sandra und Dienel, Angelika
(2017):
Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set.
In: International Clinical Psychopharmacology, Bd. 32, Nr. 4: S. 195-204
Möller, Hans-Jürgen; Bandelow, Borwin; Volz, Hans-Peter; Barnikol, Utako Birgit; Seifritz, Erich und Kasper, Siegfried
(2016):
The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practice.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 266, Nr. 8: S. 725-736